Figure 1.
Instrument completion rates in the KarMMa population treated with ide-cel. BL, baseline; EQ-5D, EuroQoL 5-dimension; ide-cel, idecabtagene vicleucel; QLQ-C30, Quality of Life C30 Questionnaire; QLQ-MY20, QLQ-C30 supplementary 20-item multiple myeloma module.